CRBP News and Press, Corbus Pharmaceuticals Holdings Inc. From 04/19/24

A look at the top 10 most actives in the United States Next.e.GO N.V. (EGOX) rose 42.2% to $0.0512 on volume of 330,264,926 shares PROSHARES TRUST (SQQQ) rose 6.4% to $12.84 on volume of 220,628,201 shares AGBA Group Holding Limited (AGBA) rose 21.4% to $1.25 on volume of 128,109,386 shar...

2024-04-19 14:34:50 ET Summary Corbus Pharmaceuticals is a biotech stock focused on precision oncology, with its flagship research project targeting Nectin-4-positive solid tumors. The company is running low on funds and has filed with the SEC to raise up to $300 million, which ma...

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 37.1% to $0.1629 on volume of 102,747,129 shares WiSA Technologies Inc. (WISA) rose 69.1% to $2.96 on volume of 24,734,833 shares Peraso Inc. (PRSO) rose 37.0% to $1.7393 on volume of 23,546,162 shares ...

A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 5.1% to $11.44 on volume of 198,678,404 shares Trio Petroleum Corp. (TPET) rose 22.1% to $0.63 on volume of 179,140,668 shares Soligenix Inc. (SNGX) rose 21.7% to $0.47 on volume of 133,754,026 shares Sup...

2024-04-12 06:40:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The best biotech stocks to buy are in companies that put a lot of resources into research and development, often with nothing to show for it for years. Regulatory hurdles make finding b...

Study enrolling patients with metastatic urothelial cancer (mUC) and other Nectin-4 enriched tumors Emerging clinical profile from CSPC’s Phase 1 China study indicates differentiation from PADCEV NORWOOD, Mass., April 02, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Ho...

2024-03-28 01:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-13 17:18:18 ET More on Corbus Pharmaceuticals Corbus: Ability To Have Best-In-Class Nectin-4 Targeting Drug Corbus Pharmaceuticals: Surging On The Back Of Great News, But I See Dark Clouds Corbus Pharmaceuticals announces proposed public offering of common st...

Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) traded at a new 52-week high today and are currently trading at $48.34. So far today, approximately 46,795 shares have been exchanged, as compared to an average 30-day volume of 332.46k shares. Corbus Pharmaceuticals Holdings, Inc...

Encouraging CRB-701 (SYS6002) First-in-Human Data Presented at ASCO-GU 2024; first patient expected to be dosed in US Ph1 study by end of March 2024 IND Application for CRB-601 cleared; Ph1 study on track to commence in Summer of 2024 Pre-clinical data for CRB-913 presented ...